Construction of Mayne Pharma and Metrics Contract Services new oral solid dose commercial manufacturing facility in Greenville, N.C., is nearly finished. This $80-million, 126,000-square-foot facility will quadruple the company s U.S. manufacturing capacity. Production is expected to bOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.